Intestinal Pseudo-Obstruction (IPO) is a rare gastrointestinal disorder that mimics the symptoms of a bowel obstruction without any physical blockage in the intestine. It is characterized by impaired muscle contractions in the gastrointestinal tract, which can lead to severe symptoms such as abdominal pain, bloating, nausea, vomiting, and difficulty passing gas and stool.
Diagnosing IPO can be challenging because it can resemble other gastrointestinal conditions like true bowel obstructions or motility disorders. Living with this condition can significantly impact a person’s quality of life due to the chronic nature of the condition and the need for ongoing medical management.
Epidemiology
The exact prevalence is difficult to determine, but it is estimated to be quite low, with a prevalence of 1 in 100,000 to 1 in 500,000 individuals. This makes it a rare condition. It can occur at any age, from infancy to late adulthood. In pediatric cases, it may be associated with congenital conditions or genetic factors.
In adults, it may be secondary to other medical conditions and has no significant gender predilection. There may be some geographic variation in the prevalence of intestinal pseudo-obstruction, but comprehensive epidemiological data are limited due to the rarity and underdiagnosis of the condition. It is likely that intestinal pseudo-obstruction occurs worldwide but may be more or less common in certain regions.
Anatomy
Pathophysiology
In a healthy digestive tract, coordinated contractions of smooth muscles propel contents forward. In IPO, there is a disruption in the normal rhythmic contractions, known as peristalsis, that move material through the intestines. This abnormal smooth muscle function can occur anywhere along the digestive tract, from the esophagus to the colon. The enteric nervous system, a network of nerves in the gut, is crucial in regulating gastrointestinal motility.
In IPO, there may be dysfunction in these nerves, leading to uncoordinated or weak contractions. This neuromuscular dysfunction can be primary (idiopathic) or secondary to other underlying conditions. The gastrointestinal tract contains cells known as interstitial cells of Cajal, which act as pacemakers to initiate and coordinate muscle contractions. In IPO, there can be a loss of normal pacemaker activity, further disrupting motility.
Over time, the muscles of the gastrointestinal tract may become thicker (hypertrophy) as they work harder to compensate for their impaired function. This hypertrophy can contribute to symptoms such as abdominal pain and bloating. The impaired motility in IPO can result in a buildup of gas, fluid, and contents in the intestines, leading to symptoms that resemble a mechanical bowel obstruction. However, unlike a true obstruction caused by a physical blockage, there is no physical barrier preventing the flow of contents.
Etiology
Metabolic Disorders: Certain metabolic conditions, such as mitochondrial diseases, can affect the energy production required for normal muscle function in the gut.
Autoimmune Disorders: Autoimmune conditions, including autoimmune autonomic neuropathy, may lead to dysfunction of the autonomic nervous system, affecting gastrointestinal motility.
Endocrine Disorders: Hormonal imbalances or disorders of the endocrine system may influence gastrointestinal motility.
Psychiatric Disorders: In some instances, psychological factors, such as stress or anxiety, can exacerbate or contribute to functional gastrointestinal disorders, including IPO.
Nutritional Deficiencies: Severe malnutrition or deficiencies in specific nutrients, such as vitamin B12 or magnesium, can affect the nerves and muscles of the gut, potentially leading to motility problems.
Genetics
Prognostic Factors
Clinical History
Crampy, colicky abdominal pain is a hallmark symptom. The pain can be severe and may come and go. Patients often experience persistent nausea and may vomit, sometimes with feculent material. IPO can cause alternating periods of constipation and diarrhea, making it difficult to pass stool.
Chronic symptoms of IPO can result in weight loss and malnutrition due to impaired nutrient absorption. The onset of IPO can vary from sudden and acute to gradual and chronic. Some individuals may experience intermittent symptoms for years before receiving a diagnosis. The duration of IPO also varies widely, with some cases resolving spontaneously and others becoming chronic conditions requiring long-term management.
Physical Examination
Physical examination findings in Intestinal Pseudo-Obstruction (IPO) can be variable. They may depend on the severity of the condition, the location of the motility disturbance, and the presence of complications. IPO can mimic the symptoms and signs of a true bowel obstruction, despite the absence of a mechanical blockage. One of the most prominent physical signs in IPO is abdominal distention.
The abdomen may appear visibly swollen and feel tense or tight to the touch due to the accumulation of gas, fluids, and stool in the intestines. On auscultation, healthcare providers may detect hyperactive bowel sounds or high-pitched tinkling sounds. These sounds result from spasmodic contractions or attempts by the intestines to move contents. In severe cases, patients may exhibit pallor or cyanosis due to impaired circulation and oxygenation.
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Toxic Megacolon
Fecal Impactation
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
The treatment of Acute Colonic Pseudo-Obstruction (ACPO) involves relieving the distension of the colon to prevent bowel ischemia and perforation. In stable patients, the initial approach may be conservative, which includes regular abdominal X-rays to monitor the colon’s diameter.
Simultaneously, efforts should be made to address and rectify the underlying causes of ACPO. These causative factors encompass correcting electrolyte imbalances, treating infections, and addressing medication-induced side effects, such as those resulting from anticholinergic drugs and opioids.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Intervention with a procedure
Surgical Care
Surgery becomes the ultimate recourse when all other interventions have proven ineffective or if the patient’s condition continues to deteriorate. There are several surgical options available, including the placement of a cecostomy tube or the performance of a colectomy.
A cecostomy entails the insertion of a tube into the cecum, allowing for drainage and decompression outside of the abdominal cavity. Alternatively, the dilated section of the intestine can be surgically removed, with the possibility of a primary anastomosis or the creation of an ostomy.
In cases where a patient develops peritonitis or experiences hemodynamic instability, likely due to bowel ischemia or perforation, it is imperative to seek immediate surgical evaluation and proceed with the resection of the compromised bowel.
Phase of management
Chronic Phase
For individuals experiencing chronic symptoms of Chronic Intestinal Pseudo-Obstruction (CIPO), the use of prokinetic agents can be beneficial in addressing difficulties with oral intake. Erythromycin, for instance, can be effective in managing acute exacerbations by stimulating motilin receptors in the bowel.
While this approach is particularly useful in a hospital setting, it has yet to demonstrate long-term efficacy. For patients who cannot tolerate erythromycin, metoclopramide is an alternative that has shown effectiveness. However, like erythromycin, its long-term treatment efficacy remains unproven.
Ongoing research is exploring the potential of prokinetic agents like prucalopride and cisapride to enhance gastric emptying and alleviate symptoms in CIPO patients. Proper nutritional assessment is crucial for individuals with CIPO. Those facing difficulties with oral intake should implement strategies such as consuming small, frequent meals and high-calorie beverages.
If these approaches do not meet caloric needs, the use of a gastrostomy tube for feeding may be considered. In cases where there is evidence of gastroparesis alongside CIPO, a jejunostomy tube might be indicated. Lastly, individuals with severe CIPO symptoms may need parenteral nutrition to effectively meet their nutritional requirements.
Medication
Future Trends
Media Gallary
References
News
Vaping’s ‘95% Safer’ Claim Debated for Youth Health
Posted on
News
Google DeepMind’s AI Revolutionizes the Search for Disease Genes
Posted on
News
Mosquitoes Pose New Challenge to Public Health
Posted on
News
3D-Printed e3-skin Redefines Wearable Health Monitoring
Intestinal Pseudo-Obstruction (IPO) is a rare gastrointestinal disorder that mimics the symptoms of a bowel obstruction without any physical blockage in the intestine. It is characterized by impaired muscle contractions in the gastrointestinal tract, which can lead to severe symptoms such as abdominal pain, bloating, nausea, vomiting, and difficulty passing gas and stool.
Diagnosing IPO can be challenging because it can resemble other gastrointestinal conditions like true bowel obstructions or motility disorders. Living with this condition can significantly impact a person’s quality of life due to the chronic nature of the condition and the need for ongoing medical management.
The exact prevalence is difficult to determine, but it is estimated to be quite low, with a prevalence of 1 in 100,000 to 1 in 500,000 individuals. This makes it a rare condition. It can occur at any age, from infancy to late adulthood. In pediatric cases, it may be associated with congenital conditions or genetic factors.
In adults, it may be secondary to other medical conditions and has no significant gender predilection. There may be some geographic variation in the prevalence of intestinal pseudo-obstruction, but comprehensive epidemiological data are limited due to the rarity and underdiagnosis of the condition. It is likely that intestinal pseudo-obstruction occurs worldwide but may be more or less common in certain regions.
In a healthy digestive tract, coordinated contractions of smooth muscles propel contents forward. In IPO, there is a disruption in the normal rhythmic contractions, known as peristalsis, that move material through the intestines. This abnormal smooth muscle function can occur anywhere along the digestive tract, from the esophagus to the colon. The enteric nervous system, a network of nerves in the gut, is crucial in regulating gastrointestinal motility.
In IPO, there may be dysfunction in these nerves, leading to uncoordinated or weak contractions. This neuromuscular dysfunction can be primary (idiopathic) or secondary to other underlying conditions. The gastrointestinal tract contains cells known as interstitial cells of Cajal, which act as pacemakers to initiate and coordinate muscle contractions. In IPO, there can be a loss of normal pacemaker activity, further disrupting motility.
Over time, the muscles of the gastrointestinal tract may become thicker (hypertrophy) as they work harder to compensate for their impaired function. This hypertrophy can contribute to symptoms such as abdominal pain and bloating. The impaired motility in IPO can result in a buildup of gas, fluid, and contents in the intestines, leading to symptoms that resemble a mechanical bowel obstruction. However, unlike a true obstruction caused by a physical blockage, there is no physical barrier preventing the flow of contents.
Metabolic Disorders: Certain metabolic conditions, such as mitochondrial diseases, can affect the energy production required for normal muscle function in the gut.
Autoimmune Disorders: Autoimmune conditions, including autoimmune autonomic neuropathy, may lead to dysfunction of the autonomic nervous system, affecting gastrointestinal motility.
Endocrine Disorders: Hormonal imbalances or disorders of the endocrine system may influence gastrointestinal motility.
Psychiatric Disorders: In some instances, psychological factors, such as stress or anxiety, can exacerbate or contribute to functional gastrointestinal disorders, including IPO.
Nutritional Deficiencies: Severe malnutrition or deficiencies in specific nutrients, such as vitamin B12 or magnesium, can affect the nerves and muscles of the gut, potentially leading to motility problems.
Crampy, colicky abdominal pain is a hallmark symptom. The pain can be severe and may come and go. Patients often experience persistent nausea and may vomit, sometimes with feculent material. IPO can cause alternating periods of constipation and diarrhea, making it difficult to pass stool.
Chronic symptoms of IPO can result in weight loss and malnutrition due to impaired nutrient absorption. The onset of IPO can vary from sudden and acute to gradual and chronic. Some individuals may experience intermittent symptoms for years before receiving a diagnosis. The duration of IPO also varies widely, with some cases resolving spontaneously and others becoming chronic conditions requiring long-term management.
Physical examination findings in Intestinal Pseudo-Obstruction (IPO) can be variable. They may depend on the severity of the condition, the location of the motility disturbance, and the presence of complications. IPO can mimic the symptoms and signs of a true bowel obstruction, despite the absence of a mechanical blockage. One of the most prominent physical signs in IPO is abdominal distention.
The abdomen may appear visibly swollen and feel tense or tight to the touch due to the accumulation of gas, fluids, and stool in the intestines. On auscultation, healthcare providers may detect hyperactive bowel sounds or high-pitched tinkling sounds. These sounds result from spasmodic contractions or attempts by the intestines to move contents. In severe cases, patients may exhibit pallor or cyanosis due to impaired circulation and oxygenation.
Toxic Megacolon
Fecal Impactation
The treatment of Acute Colonic Pseudo-Obstruction (ACPO) involves relieving the distension of the colon to prevent bowel ischemia and perforation. In stable patients, the initial approach may be conservative, which includes regular abdominal X-rays to monitor the colon’s diameter.
Simultaneously, efforts should be made to address and rectify the underlying causes of ACPO. These causative factors encompass correcting electrolyte imbalances, treating infections, and addressing medication-induced side effects, such as those resulting from anticholinergic drugs and opioids.
Surgical Care
Surgery becomes the ultimate recourse when all other interventions have proven ineffective or if the patient’s condition continues to deteriorate. There are several surgical options available, including the placement of a cecostomy tube or the performance of a colectomy.
A cecostomy entails the insertion of a tube into the cecum, allowing for drainage and decompression outside of the abdominal cavity. Alternatively, the dilated section of the intestine can be surgically removed, with the possibility of a primary anastomosis or the creation of an ostomy.
In cases where a patient develops peritonitis or experiences hemodynamic instability, likely due to bowel ischemia or perforation, it is imperative to seek immediate surgical evaluation and proceed with the resection of the compromised bowel.
Chronic Phase
For individuals experiencing chronic symptoms of Chronic Intestinal Pseudo-Obstruction (CIPO), the use of prokinetic agents can be beneficial in addressing difficulties with oral intake. Erythromycin, for instance, can be effective in managing acute exacerbations by stimulating motilin receptors in the bowel.
While this approach is particularly useful in a hospital setting, it has yet to demonstrate long-term efficacy. For patients who cannot tolerate erythromycin, metoclopramide is an alternative that has shown effectiveness. However, like erythromycin, its long-term treatment efficacy remains unproven.
Ongoing research is exploring the potential of prokinetic agents like prucalopride and cisapride to enhance gastric emptying and alleviate symptoms in CIPO patients. Proper nutritional assessment is crucial for individuals with CIPO. Those facing difficulties with oral intake should implement strategies such as consuming small, frequent meals and high-calorie beverages.
If these approaches do not meet caloric needs, the use of a gastrostomy tube for feeding may be considered. In cases where there is evidence of gastroparesis alongside CIPO, a jejunostomy tube might be indicated. Lastly, individuals with severe CIPO symptoms may need parenteral nutrition to effectively meet their nutritional requirements.
medtigo
Intestinal Pseudo-Obstruction
Updated :
September 16, 2023
Intestinal Pseudo-Obstruction (IPO) is a rare gastrointestinal disorder that mimics the symptoms of a bowel obstruction without any physical blockage in the intestine. It is characterized by impaired muscle contractions in the gastrointestinal tract, which can lead to severe symptoms such as abdominal pain, bloating, nausea, vomiting, and difficulty passing gas and stool.
Diagnosing IPO can be challenging because it can resemble other gastrointestinal conditions like true bowel obstructions or motility disorders. Living with this condition can significantly impact a person’s quality of life due to the chronic nature of the condition and the need for ongoing medical management.
The exact prevalence is difficult to determine, but it is estimated to be quite low, with a prevalence of 1 in 100,000 to 1 in 500,000 individuals. This makes it a rare condition. It can occur at any age, from infancy to late adulthood. In pediatric cases, it may be associated with congenital conditions or genetic factors.
In adults, it may be secondary to other medical conditions and has no significant gender predilection. There may be some geographic variation in the prevalence of intestinal pseudo-obstruction, but comprehensive epidemiological data are limited due to the rarity and underdiagnosis of the condition. It is likely that intestinal pseudo-obstruction occurs worldwide but may be more or less common in certain regions.
In a healthy digestive tract, coordinated contractions of smooth muscles propel contents forward. In IPO, there is a disruption in the normal rhythmic contractions, known as peristalsis, that move material through the intestines. This abnormal smooth muscle function can occur anywhere along the digestive tract, from the esophagus to the colon. The enteric nervous system, a network of nerves in the gut, is crucial in regulating gastrointestinal motility.
In IPO, there may be dysfunction in these nerves, leading to uncoordinated or weak contractions. This neuromuscular dysfunction can be primary (idiopathic) or secondary to other underlying conditions. The gastrointestinal tract contains cells known as interstitial cells of Cajal, which act as pacemakers to initiate and coordinate muscle contractions. In IPO, there can be a loss of normal pacemaker activity, further disrupting motility.
Over time, the muscles of the gastrointestinal tract may become thicker (hypertrophy) as they work harder to compensate for their impaired function. This hypertrophy can contribute to symptoms such as abdominal pain and bloating. The impaired motility in IPO can result in a buildup of gas, fluid, and contents in the intestines, leading to symptoms that resemble a mechanical bowel obstruction. However, unlike a true obstruction caused by a physical blockage, there is no physical barrier preventing the flow of contents.
Metabolic Disorders: Certain metabolic conditions, such as mitochondrial diseases, can affect the energy production required for normal muscle function in the gut.
Autoimmune Disorders: Autoimmune conditions, including autoimmune autonomic neuropathy, may lead to dysfunction of the autonomic nervous system, affecting gastrointestinal motility.
Endocrine Disorders: Hormonal imbalances or disorders of the endocrine system may influence gastrointestinal motility.
Psychiatric Disorders: In some instances, psychological factors, such as stress or anxiety, can exacerbate or contribute to functional gastrointestinal disorders, including IPO.
Nutritional Deficiencies: Severe malnutrition or deficiencies in specific nutrients, such as vitamin B12 or magnesium, can affect the nerves and muscles of the gut, potentially leading to motility problems.
Crampy, colicky abdominal pain is a hallmark symptom. The pain can be severe and may come and go. Patients often experience persistent nausea and may vomit, sometimes with feculent material. IPO can cause alternating periods of constipation and diarrhea, making it difficult to pass stool.
Chronic symptoms of IPO can result in weight loss and malnutrition due to impaired nutrient absorption. The onset of IPO can vary from sudden and acute to gradual and chronic. Some individuals may experience intermittent symptoms for years before receiving a diagnosis. The duration of IPO also varies widely, with some cases resolving spontaneously and others becoming chronic conditions requiring long-term management.
Physical examination findings in Intestinal Pseudo-Obstruction (IPO) can be variable. They may depend on the severity of the condition, the location of the motility disturbance, and the presence of complications. IPO can mimic the symptoms and signs of a true bowel obstruction, despite the absence of a mechanical blockage. One of the most prominent physical signs in IPO is abdominal distention.
The abdomen may appear visibly swollen and feel tense or tight to the touch due to the accumulation of gas, fluids, and stool in the intestines. On auscultation, healthcare providers may detect hyperactive bowel sounds or high-pitched tinkling sounds. These sounds result from spasmodic contractions or attempts by the intestines to move contents. In severe cases, patients may exhibit pallor or cyanosis due to impaired circulation and oxygenation.
Toxic Megacolon
Fecal Impactation
The treatment of Acute Colonic Pseudo-Obstruction (ACPO) involves relieving the distension of the colon to prevent bowel ischemia and perforation. In stable patients, the initial approach may be conservative, which includes regular abdominal X-rays to monitor the colon’s diameter.
Simultaneously, efforts should be made to address and rectify the underlying causes of ACPO. These causative factors encompass correcting electrolyte imbalances, treating infections, and addressing medication-induced side effects, such as those resulting from anticholinergic drugs and opioids.
Gastroenterology
Surgical Care
Surgery becomes the ultimate recourse when all other interventions have proven ineffective or if the patient’s condition continues to deteriorate. There are several surgical options available, including the placement of a cecostomy tube or the performance of a colectomy.
A cecostomy entails the insertion of a tube into the cecum, allowing for drainage and decompression outside of the abdominal cavity. Alternatively, the dilated section of the intestine can be surgically removed, with the possibility of a primary anastomosis or the creation of an ostomy.
In cases where a patient develops peritonitis or experiences hemodynamic instability, likely due to bowel ischemia or perforation, it is imperative to seek immediate surgical evaluation and proceed with the resection of the compromised bowel.
Gastroenterology
Chronic Phase
For individuals experiencing chronic symptoms of Chronic Intestinal Pseudo-Obstruction (CIPO), the use of prokinetic agents can be beneficial in addressing difficulties with oral intake. Erythromycin, for instance, can be effective in managing acute exacerbations by stimulating motilin receptors in the bowel.
While this approach is particularly useful in a hospital setting, it has yet to demonstrate long-term efficacy. For patients who cannot tolerate erythromycin, metoclopramide is an alternative that has shown effectiveness. However, like erythromycin, its long-term treatment efficacy remains unproven.
Ongoing research is exploring the potential of prokinetic agents like prucalopride and cisapride to enhance gastric emptying and alleviate symptoms in CIPO patients. Proper nutritional assessment is crucial for individuals with CIPO. Those facing difficulties with oral intake should implement strategies such as consuming small, frequent meals and high-calorie beverages.
If these approaches do not meet caloric needs, the use of a gastrostomy tube for feeding may be considered. In cases where there is evidence of gastroparesis alongside CIPO, a jejunostomy tube might be indicated. Lastly, individuals with severe CIPO symptoms may need parenteral nutrition to effectively meet their nutritional requirements.
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
